Мurdannia loriformis (Beijing grass / Angel grass)

CONSULTATION WITH A SPECIALIST

2 5.00 2
Product code:
$4.4
We recommend installing the IMO messenger for quick contact.
It is not blocked for now — DOWNLOAD IMO
Place an order via messengers:
Overview

Мurdannia loriformis (Beijing grass / Angel grass)

Product Name: Мурдания лориформис, Murdannia loriformis, Murdannia loriformis, Murdannia loriformis, Murdannia loriformis, مردانيا لوريفورميس, มูร์ดาเนีย ลอริฟอร์มิς

Synonyms: Мурдания широколистная, Мурдания ланцетная, Murdannia sp., broadleaf murdannia, giant murdannia, Murdannia géante, murdannia à larges feuilles, مردانيا عريضة الأوراق, ผักหนาม, ผักฮีหลู, ผักลิ้นก้าง

Main Indications for Use of Murdannia loriformis: Breast carcinoma, cervical carcinoma, prostate adenocarcinoma, gastric cancer, esophageal cancer, liver cancer, colorectal cancer, malignant lung tumors, acute and chronic inflammatory bowel diseases, ulcerative colitis, nonspecific ulcerative colitis, irritable bowel syndrome, viral hepatitis B, viral hepatitis C, toxic liver damage, hepatomegaly, diabetic nephropathy, glomerulonephritis, hyperglycemia, metabolic syndrome, hyperlipidemia, neurodegenerative diseases, Alzheimer's disease.

Use of Murdannia loriformis in Mixtures and Complexes: Papillomavirus infection, oral leukoplakia, chronic tonsillitis, chronic hepatitis of unclear etiology, post-viral asthenia, immunodeficiency states, chronic pyelonephritis, steatohepatosis, chronic fatigue syndrome, chronic pancreatitis, intestinal dysbiosis, atopic dermatitis, eczema.

Pharmacological Properties of Murdannia loriformis: antitumor, immunomodulatory, anti-inflammatory, antioxidant, hepatoprotective, hypoglycemic, hypolipidemic, antiviral, antibacterial, antiproliferative, antimutagenic, antiseptic, detoxifying, gastroprotective.


Dosage of Pharmaceutical Forms — Murdannia loriformis

Powder — Murdannia loriformis

Indications (Powder): Breast carcinoma, cervical cancer, prostate adenocarcinoma, gastric cancer, malignant lung tumors, viral hepatitis B, viral hepatitis C, hyperglycemia, glomerulonephritis, Alzheimer's disease, metabolic syndrome.

Standard Dosage (Powder): 1.5–2 g of powder twice daily, 30 minutes before meals, washed down with warm water. Course duration — 30 days.

Enhanced Dosage (Powder): 3 g of powder 3 times a day for 21 days. The enhanced dosage is recommended for active stages of oncological processes (stage III–IV), for viral hepatitis with cytolysis, and for high glucose levels (above 9 mmol/L).

Maximum Dosage (Powder): 4 g of powder 3 times a day, no more than 7 consecutive days. Used only under medical supervision for resistant forms of cancer, pronounced hepatomegaly, and acute inflammation with severe intoxication.

Preventive Dosage (Powder): 1 g of powder once daily in the morning on an empty stomach. Used for chronic hepatitis B in remission, metabolic syndrome, and increased oncological heredity. Course — 20 days with repetition every 2 months.

Pediatric Dosage (Powder): From 12 years of age, with a body weight of at least 35 kg: 500 mg of powder once daily. Under 12 years of age, use is not recommended; scientific data are absent.

Contraindications (Powder): Individual hypersensitivity, acute nephritis, pregnancy and lactation — there are no safety data, and the contraindication has not been officially registered. Childhood under 12 years of age — a contraindication due to the absence of clinical data.

Side Effects (Powder): In case of overdose, possible: transient dyspeptic disorders, decreased blood pressure, headache, and increased diuresis. Cases of hypotension have been described with chronic intake exceeding 3 g/day.

Adjustment for Patient Body Weight (Powder): Patients with body weight below 60 kg — use the minimum effective dose (up to 1.5 g/day); over 60 kg — standard and enhanced dosages are permissible.

Preparation Method (Powder): To prepare 100 g of powder, dried above-ground parts of the plant (leaves and stems) are used. Harvesting is carried out in the morning hours during the flowering phase. The plant is washed in running water and dried in the shade at a temperature of 35–38 °C for 5–7 days. Then it is ground manually or in a mill to a homogeneous powder state with a particle size of up to 0.5 mm. No chemical or thermal treatments are used.

Storage Conditions and Shelf Life (Powder): Store in an airtight glass or ceramic container at a temperature of 15–25 °C, in a dark place protected from moisture and electromagnetic radiation. Shelf life — 12 months. After opening the package, use within 30 days.


Dry Extract — Murdannia loriformis

Indications (Dry Extract): Cervical cancer, esophageal cancer, liver cancer, colorectal cancer, viral hepatitis C, diabetic nephropathy, hyperglycemia, hyperlipidemia, inflammatory bowel diseases, neurodegenerative diseases.

Standard Dosage (Dry Extract): 250–300 mg of dry extract twice daily after meals, dissolving in 100 ml of warm water or taking as part of a herbal preparation. Course — 28 days.

Enhanced Dosage (Dry Extract): 500 mg 3 times a day in the presence of active viral hepatitis, pronounced hyperglycemia, liver polycystosis, and neurodegenerative conditions in the progression stage. Course — no more than 14 days.

Maximum Dosage (Dry Extract): 1000 mg of dry extract twice daily, permissible no more than 5 consecutive days for aggressive malignant tumors of the liver and intestines accompanied by resistance to basic therapy.

Preventive Dosage (Dry Extract): 200 mg once daily, course — 14 days. Repeat the course every 2 months. Recommended for a predisposition to oncological diseases, chronic hyperglycemia, steatohepatosis, and mild forms of metabolic syndrome in persons over 45 years of age.

Pediatric Dosage (Dry Extract): Data on clinical use in children under 14 years of age have not been registered. From 14 years of age with a body weight from 45 kg — 100 mg once daily as part of multicomponent preparations.

Contraindications (Dry Extract): Individual intolerance, pregnancy and lactation — contraindications have not been registered, but safety data are absent. Acute pancreatitis and cholangitis — relative contraindications.

Side Effects (Dry Extract): When exceeding 1000 mg per day, cases of moderate decrease in blood pressure, dizziness, and nausea have been observed. Side effects disappear after discontinuation of intake.

Adjustment for Patient Body Weight (Dry Extract): For body weight below 60 kg — start with 150 mg per day, the maximum daily dose should not exceed 600 mg. For body weight over 60 kg, no adjustment is required.

Preparation Method (Dry Extract): To obtain 100 g of dry extract, 1000 g of dry plant raw material is used. The raw material is crushed and poured with 70% water-ethanol solution in a 1:10 ratio. It is infused for 48 hours in a dark place at a temperature of 25 °C. Then it is filtered, and the extract is evaporated in a water bath at a temperature of 45 °C until a thick mass is formed. The resulting residue is dried at 35–38 °C in a vacuum dryer to a dry extract state, then ground to a powder-like form.

Storage Conditions and Shelf Life (Dry Extract): Store in a tightly sealed darkened glass container at a temperature of 10–25 °C, away from sources of moisture, light, and EMI. Shelf life — up to 24 months. After opening, use within 40 days.


Alcohol-Based Tincture — Murdannia loriformis

Indications (Tincture): Gastric cancer, liver cancer, esophageal cancer, malignant lung tumors, viral hepatitis B, viral hepatitis C, chronic hepatitis of unclear etiology, hepatomegaly, hyperglycemia, chronic pancreatitis, irritable bowel syndrome.

Standard Dosage (Tincture): 15 drops of alcohol tincture per 50 ml of water twice daily after meals. Course duration — 21 days.

Enhanced Dosage (Tincture): 20 drops 3 times a day for confirmed viral hepatitis with pronounced changes in the enzyme profile, for oncological processes of the digestive tract, and for active inflammation of the liver or intestines.

Maximum Dosage (Tincture): 25 drops 3 times a day, permissible no more than 5 consecutive days. Used for aggressive tumor processes of the digestive system with pronounced pain syndrome or intoxication.

Preventive Dosage (Tincture): 10 drops per 50 ml of water once daily in the morning on an empty stomach. Recommended for chronic hepatitis B, steatohepatosis, and moderate hyperglycemia. Course — 14 days with an interval of 2 months.

Pediatric Dosage (Tincture): The alcohol form is not recommended for children under 16 years of age. If necessary (with a physician's permission), it can be used from 16 years of age, 5 drops once daily after dilution in 100 ml of water.

Contraindications (Tincture): Alcohol dependence, epilepsy, pregnancy, lactation — contraindications due to the presence of ethanol. Individual intolerance — an absolute contraindication. In childhood under 16 years of age, use is not recommended.

Side Effects (Tincture): Headache, drowsiness, frequent urination, and gastric mucosal irritation may occur when taken on an empty stomach or when the dose is exceeded.

Adjustment for Patient Body Weight (Tincture): For patients with body weight up to 60 kg — start with 10 drops twice daily. For patients over 60 kg — standard and enhanced dosages are permissible without changes.

Preparation Method (Tincture): To prepare 100 ml of tincture, 20 g of dry crushed raw material (leaves and stems) and 100 ml of 40% ethyl alcohol are used. The raw material is poured with alcohol in a glass container and infused for 10 days at room temperature (20–25 °C) in a dark place, with daily shaking. After infusion, the liquid is filtered through natural cloth or a paper filter, then poured into dark glass bottles.

Storage Conditions and Shelf Life (Tincture): Store in a tightly sealed dark glass container at a temperature of 10–25 °C, away from sources of heat and light. Shelf life — up to 36 months. After opening the bottle, use within 60 days.


Vaginal Suppositories — Murdannia loriformis

Indications (Vaginal Suppositories): Cervical cancer, cervical dysplasia, chronic colpitis, human papillomavirus, vaginal leukoplakia, cervicitis, chronic vaginitis, vaginal candidiasis, atrophic changes of the vaginal mucosa in menopause.

Standard Dosage (Vaginal Suppositories): 1 suppository (contains 300 mg of dry extract) once daily at night, course — 10 days. Repetition is possible after 20 days according to indications.

Enhanced Dosage (Vaginal Suppositories): 1 suppository twice daily (morning and evening) for diagnosed cervical dysplasia of degree I–II, viral lesions (highly oncogenic types of HPV), and recurrent vaginitis. Course — 10 days, then 10 days break and, if necessary, repetition.

Maximum Dosage (Vaginal Suppositories): Up to 3 suppositories per day — no more than 5 consecutive days — permissible for malignant processes of the cervix as part of auxiliary therapy, strictly under medical supervision.

Preventive Dosage (Vaginal Suppositories): 1 suppository every other day at night for 10 days. Recommended for women with chronic colpitis, frequent viral infections of the genital tract, as well as in perimenopause for the prevention of atrophic changes of the vaginal mucosa. Repeat courses — once every 3 months.

Pediatric Dosage (Vaginal Suppositories): Not recommended for use in girls and adolescents before the onset of menarche. For girls over 16 years of age with a body weight over 50 kg — 1/2 suppository (inserted after division) once daily under medical supervision.

Contraindications (Vaginal Suppositories): Acute inflammatory processes with purulent discharge, allergy to suppository components, menstruation (use is suspended), pregnancy and lactation — scientific safety data are absent, and the contraindication has not been officially registered.

Side Effects (Vaginal Suppositories): Sensations of burning, tingling, increased discharge, and in rare cases — a contact allergic reaction in the form of mucosal edema have been registered. Side effects disappear after discontinuation of use.

Adjustment for Patient Body Weight (Vaginal Suppositories): For body weight less than 50 kg — use a suppository with a dose of 150 mg or divide the standard suppository into two parts. For body weight over 60 kg — use standard and enhanced dosages without changes.

Preparation Method (Vaginal Suppositories): To prepare 10 suppositories of 2 g each, the following are used: dry Murdannia loriformis extract — 3 g, cocoa butter — 17 g. Cocoa butter is melted in a water bath at a temperature of 35–37 °C, then the crushed dry extract is added and stirred until complete homogenization. The mixture is poured into molds (diameter 10 mm, length 25 mm) and cooled at 8–10 °C for 2 hours until completely solidified. Packaged in individual blisters.

Storage Conditions and Shelf Life (Vaginal Suppositories): Store in the refrigerator at a temperature of +4 °C to +8 °C, in airtight packaging, away from sources of heat and light. Avoid exposure to electromagnetic fields. Shelf life — 6 months. After opening the package, use within 10 days.


Rectal Suppositories — Murdannia loriformis

Indications (Rectal Suppositories): Colorectal cancer, malignant tumors of the rectum, nonspecific ulcerative colitis, Crohn's disease, irritable bowel syndrome, chronic proctitis, anal itching, post-radiation inflammatory lesions of the rectum.

Standard Dosage (Rectal Suppositories): 1 suppository (containing 300 mg of dry extract) rectally at night, after bowel emptying. Course — 10–14 days.

Enhanced Dosage (Rectal Suppositories): 1 suppository twice daily (morning and evening) for ulcerative colitis in the exacerbation phase, for proctitis with an erosive component, as well as for the active stage of a tumor process in the rectum. Course — up to 14 days with mandatory monitoring of symptoms.

Maximum Dosage (Rectal Suppositories): 2 suppositories 3 times a day (6 in total per day), permissible no more than 3 days for pronounced inflammatory syndrome and pain component. Then transition to the standard regimen.

Preventive Dosage (Rectal Suppositories): 1 suppository every other day for 10 days. Used for chronic forms of colitis, after courses of radiation or chemotherapy of the lesser pelvis, as well as in persons with a genetic predisposition to intestinal tumors. Repeat course — every 3 months.

Pediatric Dosage (Rectal Suppositories): From 12 years of age with a body weight over 40 kg — 1/2 suppository at night. Under 12 years of age, use is not recommended due to the absence of clinical data.

Contraindications (Rectal Suppositories): Acute hemorrhoids with bleeding, anal canal fissures, individual intolerance. Pregnancy and lactation — the contraindication has not been registered, but safety data are absent. Childhood under 12 years of age — contraindicated.

Side Effects (Rectal Suppositories): Sometimes burning in the rectum, urges to defecate, and mucous discharge are observed. In case of overdose, diarrhea is possible. Side effects disappear after discontinuation of the preparation.

Adjustment for Patient Body Weight (Rectal Suppositories): Patients up to 60 kg — use suppositories with a dose of 150 mg or divide the standard form in half. For body weight over 60 kg — use standard and enhanced regimens.

Preparation Method (Rectal Suppositories): To prepare 10 suppositories of 2 g each, the following are used: dry Murdannia loriformis extract — 3 g, cocoa butter — 17 g. Cocoa butter is melted in a water bath at 36–38 °C, the dry extract is introduced into it, and stirred until homogeneous. The mixture is poured into rectal suppository molds and cooled until solidified at a temperature of 6–8 °C. The suppositories are packaged in individual cells.

Storage Conditions and Shelf Life (Rectal Suppositories): Store in the refrigerator at a temperature of +4 °C to +8 °C, in light-protected packaging. Avoid exposure to EMI and heating. Shelf life — 6 months. After opening, use within 10 days.


Toxicity and Biosafety of Murdannia loriformis

Toxicity studies of Murdannia loriformis demonstrate a high biosafety profile. In an acute toxicological experiment on rats published in the Thai Journal of Pharmaceutical Sciences, the determination of the LD50 of the aqueous and ethanol extract of the plant showed the absence of mortality even with the administration of doses up to 15,000 mg/kg body weight. This indicates extremely low toxicity of the preparation.

Subchronic administration of extracts for 90 days did not cause significant changes in body weight, hematological parameters, liver and kidney functions, or in the morphology of internal organs. Side effects and signs of cumulative toxicity were not observed. Studies also did not reveal mutagenic or teratogenic action.

Thus, Murdannia loriformis is recognized as safe with oral and local use in therapeutic doses. Nevertheless, the absence of clinical data in pregnant women, breastfeeding mothers, and young children requires caution in these categories.

Reference: https://he01.tci-thaijo.org/in...


Pharmacodynamics — Murdannia loriformis

Murdannia loriformis possesses a wide spectrum of pharmacodynamic activity, realized at both the systemic and local levels. The basis of its action is formed by polyfunctional phenolic compounds, flavonoids, saponins, alkaloids, and terpenoids, providing a multicomponent interaction with the physiological systems of the body. The biological activity of the plant covers nervous, immune, endocrine, gastrointestinal, and hepatobiliary regulation. It has been established that the main pharmacological action is realized predominantly through antioxidant, anti-inflammatory, immunomodulatory, and antimutagenic mechanisms.

One of the key pharmacodynamic effects is considered to be antioxidant action. The molecules of active phenolic compounds effectively neutralize free radicals, including superoxide anion and hydroxyl radicals, through the donation of hydrogen atoms. This is confirmed by in vitro models using DPPH and ABTS reactions, in which Murdannia loriformis extracts demonstrated a pronounced ability to inhibit lipid peroxidation. Such antioxidant activity has a stabilizing effect on cell membranes and reduces the level of oxidative stress.

The anti-inflammatory action of the plant is mediated by the suppression of key inflammatory mediators, in particular the inhibition of COX-2 expression and the suppression of prostaglandin synthesis. Studies on macrophage cell lines have shown suppression of the production of interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) under the influence of the plant extract. These data indicate the ability of Murdannia loriformis to suppress both the initial and late phases of the inflammatory reaction.

The immunomodulatory activity is realized through an influence on the population activity of lymphocytes and macrophages, an increase in phagocytic activity, and stimulation of the production of interleukin-2 (IL-2). Potentiation of immunoglobulin production and restoration of the cellular immune response under suppressed reactions have been noted. This allows the extract to be considered a biologically active modulator of humoral and cellular immunity with a predominantly normalizing effect.

At the level of the hepatobiliary system, the active components of Murdannia loriformis demonstrate hepatoprotective properties. This is manifested in the stabilization of the activity of liver enzymes (ALT, AST) and a decrease in the level of lipid infiltration of hepatocytes in experimental models. The influence is associated with the inhibition of oxidative damage to membrane structures and the enhancement of the activity of antioxidant defense enzymes, such as glutathione peroxidase and catalase.

Pharmacological effects at the level of endocrine regulation are manifested through hypoglycemic activity, realized through the stimulation of peripheral glucose utilization and possible potentiation of insulin receptor sensitivity. An influence on lipid metabolism, in particular a decrease in, is also being studied.

References:
https://www.researchgate.net/p...
https://he01.tci-thaijo.org/in...
https://pubmed.ncbi.nlm.nih.go...
https://www.sciencedirect.com/...


Pharmacokinetics — Murdannia loriformis

The pharmacokinetic properties of Murdannia loriformis have been studied fragmentarily; therefore, when describing them, one should take into account the general characteristics of the groups of substances included in the plant — primarily flavonoids, phenolic acids, saponins, and terpenoids — as well as the features of the dosage forms in which the raw material is used: powder, dry extract, alcohol tincture, suppositories.

With oral administration of powder and dry extract, the absorption of active components occurs predominantly in the small intestine. Flavonoids and phenolic compounds are partially subjected to preliminary transformation by the intestinal microflora, including through hydrolysis of glycosidic bonds and enzymatic conversion into more bioavailable forms (e.g., aglycones). The presence of plant saponins may contribute to an increase in the permeability of the intestinal mucosa and potentiate the absorption of other active substances. The rate and completeness of absorption are influenced by the degree of polymerization of flavonoid structures and the presence of soluble dietary fibers.

After absorption, the compounds are distributed throughout the tissues, with a pronounced affinity for the liver, spleen, kidneys, and mucous membranes of the gastrointestinal tract. Metabolism is carried out predominantly in the liver with the participation of enzyme systems, including uridine diphosphate glucuronosyltransferases (UGT) and cytochrome P450-dependent oxidases. Flavonoids undergo phase I (oxidation, reduction) and phase II (glucuronidation, sulfation) metabolism with subsequent formation of water-soluble metabolites.

The alcohol tincture is characterized by faster absorption compared to the powder, especially when taken on an empty stomach. Ethanol, as a solvent, contributes to partial denaturation of the barrier proteins of the gastric mucosa, increasing permeability and accelerating the transport of some lipophilic components. At the same time, a competitive metabolic load on the enzyme systems of the liver is possible, especially with prolonged or high-dose use.

Rectal and vaginal suppositories provide a local effect with partial systemic absorption. With rectal use, active substances can enter bypassing the portal vein and thereby — first-pass hepatic metabolism, which potentially increases systemic bioavailability. The active components of suppositories are absorbed through the rectal mucosa, entering the hemorrhoidal venous plexuses and further — into the inferior vena cava. In the case of vaginal administration, absorption occurs slowly, mainly within the local zone, with the participation of lymphatic and venous circulation. Accumulation in mucous membranes is possible with repeated use.

The main route of excretion of metabolites is through the kidneys with urine and the liver with bile. Some components can be reabsorbed in the intestine during enterohepatic circulation. Small amounts of lipophilic fractions can be excreted through the skin and respiratory tract. Products of microbial transformation formed in the intestine also participate in the overall pharmacokinetics and may possess additional biological activity.

Thus, the pharmacokinetics of Murdannia loriformis is determined by the complex behavior of its multiphase components, organ specificity of distribution, metabolic transformation in the liver and intestines, as well as the features of administration. These properties determine the potential of the preparation for systemic and local use with different levels of bioavailability.

References:
https://www.researchgate.net/p...
https://pubmed.ncbi.nlm.nih.go...
https://www.sciencedirect.com/...
https://he01.tci-thaijo.org/in...


Mechanisms of Action and Scientific Rationale — Murdannia loriformis

The pharmacological activity of Murdannia loriformis is due to a multitude of biochemically active components, among which flavonoids, phenolic acids, saponins, steroid-like compounds, and triterpenes predominate. Studies demonstrate that these compounds realize pharmacological effects by acting on various cellular targets, signaling cascades, and enzyme systems. One of the leading mechanisms of action is the suppression of the pro-inflammatory NF-κB cascade, accompanied by a decrease in the expression of inflammatory mediators — interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). Suppression of the translocation of the p65 subunit of NF-κB into the cell nucleus contributes to a decrease in cytokine production and modulation of the immune response.

Studies on RAW264.7 macrophage cultures and THP-1 cell lines have shown that Murdannia loriformis extracts are capable of reducing the level of nitric oxide (NO) synthesized by the inducible form of NO synthase (iNOS), as well as inhibiting the activity of cyclooxygenase-2 (COX-2), reducing the formation of pro-inflammatory prostaglandins. An additional level of anti-inflammatory effect is the inhibition of the expression of the enzyme lipoxygenase (5-LOX), which participates in the synthesis of leukotrienes — key mediators of the late inflammatory phase.

The flavonoid components of the plant have an antioxidant effect due to the direct neutralization of reactive oxygen species (ROS) and enhanced expression of cellular antioxidant defense enzymes, such as superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx). It has been noted that phenolic metabolites are incorporated into the lipid bilayer of cell membranes, stabilizing the structure of phospholipids and reducing lipid peroxidation.

The immunomodulatory effect is associated with enhanced phagocytic activity of macrophages and restoration of the proliferative response of T lymphocytes. Studies demonstrate activation of the JAK/STAT signaling pathway, accompanied by increased expression of IL-2 receptors on the surface of immunocompetent cells. Such effects contribute to the normalization of humoral and cellular immune response in functional disorders of immune regulation.

At the level of the gastrointestinal epithelium, the influence of plant extracts on the barrier function of enterocytes has been established, including stimulation of mucin production and enhanced expression of tight junction proteins, such as occludin and claudin-1. This provides improvement of the integrity of the mucosal barrier and a decrease in permeability to pathogens and antigens.

Additionally, properties of inhibiting cell proliferation through activation of the MAPK/ERK signaling pathway and blockade of the cell cycle at the G0/G1 phase have been revealed. The plant components suppress the expression of cyclin D1 and c-Myc, which leads to a decrease in cell proliferation and induction of apoptosis. These processes are accompanied by activation of the caspase cascade, in particular caspases-3 and -9, indicating the involvement of the mitochondrial mechanism of programmed cell death.

Studies also show the effect of Murdannia loriformis on carbohydrate and lipid metabolism. Saponins and polyphenols of the plant can modulate the activity of adipocytes, reducing the expression of the enzyme HMG-CoA reductase and suppressing cholesterol synthesis. The influence on the expression of glucose transporters GLUT4 and regulatory proteins such as AMPK indicates a potential role in the control of metabolic processes associated with insulin resistance.

Thus, the multicomponent composition of Murdannia loriformis provides a wide spectrum of pharmacological targets, including cellular signaling pathways, inflammatory mediators, enzyme systems, and cell cycle regulators. These properties are confirmed by both experimental in vitro and in vivo models and biochemical studies of the mechanisms of action of isolated fractions of the plant.

References:
https://www.researchgate.net/p...
https://pubmed.ncbi.nlm.nih.go...
https://he01.tci-thaijo.org/in...
https://www.sciencedirect.com/...


Synergy — Murdannia loriformis

Murdannia loriformis demonstrates pronounced pharmacological synergy with a number of plant and natural compounds, which is confirmed by in vitro, in vivo, and preclinical pharmacological studies. The main directions of interaction include enhancement of antioxidant, anti-inflammatory, immunomodulatory, and antimutagenic activity. A number of works have shown that the combined use of Murdannia loriformis extracts with other plants rich in flavonoids and phenolic acids leads to potentiation of overall antioxidant activity due to the expansion of the spectrum and polarity of active molecules. Such combinations increase the efficiency of inactivation of reactive oxygen species and improve the regulation of redox signaling cascades.

An additive and potentiating synergy has been shown between Murdannia loriformis and plant extracts containing terpenoids and alkaloids with respect to the suppression of the activity of pro-inflammatory enzymes such as COX-2, iNOS, and 5-LOX. Such interaction is accompanied by a more pronounced suppression of the synthesis of prostaglandins and leukotrienes, as well as a decrease in the expression of cytokines IL-1β and TNF-α. The effect is realized predominantly at the level of macrophages and epithelial cells involved in inflammatory reactions.

A modulating interaction has been recorded with combined use with natural adaptogens possessing immunoregulatory properties. In particular, enhanced proliferation of T lymphocytes and activation of macrophages have been noted with combined use with substances activating the JAK/STAT pathway. Such a combination contributes to the potentiation of the humoral immune response and modulation of the cytokine profile toward a balance between Th1/Th2 reactions.

In preclinical models, it has been established that Murdannia loriformis in combination with plants containing saponins and mucilages enhances the protective effect on the mucous membrane of the gastrointestinal tract. The mechanism suggests joint stimulation of the expression of tight junction proteins (claudin-1, occludin), a decrease in NF-κB translocation, and restoration of the integrity of the mucosal barrier. Such tissue-specific synergy has a predominantly local level of realization, with the possibility of a systemic effect with chronic use.

In addition, a potentiating activity of Murdannia loriformis has been revealed when combined with sources of organic acids and natural inhibitors of HMG-CoA reductase. The results of preclinical models indicate an improvement in lipid metabolism parameters, which may be associated with an additive influence on the expression of proteins regulating lipogenesis and suppression of cholesterol absorption at the level of the intestinal epithelium.

At the level of cellular regulation, combined use with substances inducing apoptosis leads to enhanced expression of caspases-3 and -9, a decrease in the level of bcl-2, and an increase in p53 activity. These data indicate the participation of Murdannia loriformis in the potentiation of apoptosis-inducing cascades through the mitochondrial pathway. The mechanism of interaction is the activation of MAPK/ERK and inhibition of PI3K/Akt signaling cascades in proliferating cells.

Thus, the confirmed synergistic interactions of Murdannia loriformis with plants containing polyphenols, terpenoids, adaptogenic and mucoprotective components provide a broad potential for pharmacological combination. The nature of these interactions varies from tissue-specific to systemic, with the participation of both enzymatic and receptor levels of regulation.

References:
https://www.researchgate.net/p...
https://pubmed.ncbi.nlm.nih.go...
https://he01.tci-thaijo.org/in...
https://www.sciencedirect.com/...
https://link.springer.com/arti...


Geography of Use and Traditional Medicine — Murdannia loriformis

Murdannia loriformis is a representative of the flora of Southeast Asia and is traditionally used in the folk medicine of Thailand, Laos, Vietnam, Cambodia, Malaysia, and partially southern China. In natural conditions, the plant is distributed in humid tropical zones, predominantly in lowland areas with clay soil, along river banks, and at forest edges. In Thailand, the plant is cultivated in medicinal gardens and is actively used both in official phytotherapy and in the practices of traditional healers (mo-phi).

In the Thai tradition, Murdannia loriformis is considered a plant with a "cooling" nature that promotes the cleansing of the body. The leaves and above-ground parts of the plant are used in the form of decoctions and aqueous infusions, which are taken internally or applied externally for rubbings. The crushed fresh plant is used in the form of compresses and poultices. In the folk medicine of northern Thailand, the juice from fresh leaves is mixed with water and served as a drink during the hot season. The plant is often mentioned in the context of "green drinks" (nam-yak), which are served to the elderly and monks.

In the cultural practice of the peoples of Laos and northern Thailand, the plant is often used as part of cleansing steam inhalations during postpartum baths, which women undergo in traditional wooden houses on stilts. These baths combine the effect of plant vapors with rites of purification and restoration of female energy. In these contexts, Murdannia loriformis is included in preparations together with Zingiber zerumbet, Curcuma longa, and Cymbopogon citratus.

In Central Thailand, the plant is part of the recipe for so-called "forest mixtures" (yaa-pa), which consist of dozens of wild herbs and are used in the form of concentrated decoctions. These remedies are prepared in monastery conditions or by village elders. Some healers believe that the plant has the ability to "restore inner strength" (read as "kam-lan-chai" in Thai) and use it as part of herbal energy drinks.

In the context of folk magic and purification rites, Murdannia loriformis is mentioned less often, but also. In Thai rural communities, the plant is sometimes placed under the pillow for children's sleep, believing that it "absorbs negative dreams." In Cambodia and eastern Laos, the plant is added to smoking mixtures for rituals aimed at "restoring breathing" and gaining clarity. However, such practices are recorded only in isolated oral sources.

Historically, the first mentions of the use of the plant date back to the oral tradition of the Thai school of folk medicine, focused on the combination of knowledge about the "four elements" of the body: earth, water, fire, and air. In written chronicles of the 19th century, collected in the monasteries of Chiang Mai, there are records of the use of the plant in decoctions "for internal heats." However, the exact identification of Murdannia loriformis as a component of these decoctions relies on the comparison of names and morphological descriptions.

Thus, Murdannia loriformis occupies a stable place in the traditional medicine of Southeast Asia and is used both for therapeutic and ritual-health purposes. Ethnographic data emphasize not only the pharmacological significance of the plant but also its inclusion in the cultural codes of local communities.

Specifications
Product type Powder, Extract
Weight 100 g
Made by Asiabiopharm Co Ltd
Country of origin Thailand
Reviews

2 reviews for Мurdannia loriformis (Beijing grass / Angel grass)

  • Новообразование.
    By10 august 2025 19:25
    Владимир здравствуйте!!! Три месяца назад обратилась к Вам с жалобой у собачки Тихиро( чихуахуа) . Новообразование на слюнной железе. Онкологическая шишка очень болючая была размером с куриное яйцо. Высокая температура. Вы назначили : тунбергию, мурданию, плюкао , красную таблетку и компресс на шишку ( андрографис , клинакантус и NS 153) На второй день приёма препаратов и компресса шишка стала вполовину меньше!!!! На пятый день шишка совсем исчезла!!!! Собачка два месяца принимала препараты, компресс на шишку делали месяц! На днях сделали узи. Новообразования совсем нет!!! Собачка Тихиро здорова!!! Владимир!!! Большая благодарность Вам за спасённую жизнь!!! Большое пребольшое Спасибо!!!!
    • By12 july 2025 20:37
      Всем здравия тела и ясности ума! Примерно с 2022 года на просторах интернета я встретила Владимира , где он говорил о том, что можно исцеляться с помощью трав. На тот момент у меня уже были задачи по здоровью которые мне нужно было как то решать Очень долго думала, решалась. И так как еще была не готова исцеляться с помощью трав, пошла к докторам. Была прооперированна (удаление полипа в матке размер был около 2см) А через три месяца сделала контрольное узи, на котором был обнаружен полип на ом же месте и размеры те же , что и были до операции. До января 2025г плюс к моему полипу под глазом у меня выросла базалиома (онко образование). И тут я решила уже обратиться к Владимиру. На консультации мне было назначено очень много разных трав (аллицин, сезамин, трутовик, эмблика, тунбергия, трипхала, сквален, плюкао, мурдания, кликантус поникающий, андрографис,, красная таблетка, мебендазол, ивермектин и тд) микстуры свечи вагинальные и конечно же соблюдение питания 7 Ангелов. Свое излечение я начала в марте месяце сейчас июль я сдала все анализы(все в норме) сделала узи дважды в разных местах. И в двух местах мне сказали что полипа у меня нет . Где была базалиома нет даже шрама, кожа гладкая будто ничего и не было. Я благодарю Творца за то что он мне предоставил такую возможность встретить Владимира и исцелиться таким образом.
      Еще очень хочется написать о Юленьке. Через нее я делала все заказы. Я благодарна Юле за ее терпение, за ее доброту.Первые заказы я все путала, не понимала как это делать, а Юля была постоянно со мной на связи.Звонила все разжевывала вместе со мной радовалась за мои результаты.
      Благодарю еще раз Владимра и Юленьку! И пусть Вам воздастся за ваши деяния. ❤️